- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- The 10 Poorest States in America
From a monetary standpoint, the period of mid-April through September is the most dangerous part of the year for the markets. Here's why.
Janet Yellen is the only latest Central Banker to warn of high stock prices. Perhaps central banks around the world should stop buying so many stocks if they're so worried.
Yellen and Fischer are focusing on unemployment and inflation over growth to time a rate hike. With unemployment headed down and inflation up, a June rate hike is still possible.
Greece's government claims €2.5 billion will be collected from a measure to seize cash from local governments. But is that true? And will it be enough?
Cramer has been a big believer in Opko Health, which has been on a run since Pfizer put down nearly $300 million for one of its drugs. More upside possible?
Greece looks set to get kicked out of the Eurozone in a matter of days or weeks. Here's why, and here's what you can do to prepare.
The Nikkei has been chugging higher ever since Abenomics began, but direct BOJ asset purchases in the Japanese stock market may be soon coming to an end.
Vanda's Hetlioz is not the prettiest approval story, but over 350 prescriptions since February for a $60,000 orphan drug is not horrible. It'll need 1,500 prescriptions to break even.
Raptor released positive phase 3 data for its Huntington's treatment in February, but since then little has happened. The share price is now depressed, presenting a good entry point.
Before anything, there is the money supply. Stocks can rise only if the money supply is increasing. Right now it isn't.